Jiashuo Zheng (Jashuo Zheng, Huijun Chen)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Renal Cell Carcinoma

Replacement Therapy

Cell Cycle Arrest

Top Venues

The Journal of nutrition

EMBO molecular medicine

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Hamed Alborzinia, Zhiyi Chen, Umut Yildiz, Florencio Porto Freitas, Felix C E Vogel, Julianna Patricia Varga, Jasmin Batani, Christoph Bartenhagen, Werner Schmitz, Gabriele Büchel, Bernhard Michalke, Jiashuo Zheng, Svenja Meierjohann, Enrico Girardi, Elisa Espinet, Andrés F Flórez, Ancely Ferreira Dos Santos, Nesrine Aroua, Tasneem Cheytan, Julie Haenlin, Lisa Schlicker, Thamara Nishida Xavier da Silva, Adriana Przybylla, Petra Zeisberger, Giulio Superti-Furga, Martin Eilers, Marcus Conrad, Marietta Fabiano, Ulrich Schweizer, Matthias Fischer, Almut Schulze, Flavia Carla Meotti, José Pedro Friedmann Angeli
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma. EMBO molecular medicine (2023)
Eikan Mishima, Toshitaka Nakamura, Jiashuo Zheng, Weijia Zhang, André Santos Dias Mourão, Peter Sennhenn, Marcus Conrad
DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition. Nature 619 (7968) (2023)
Min Chen, En Xu, Chong Zeng, Wenjie Zhu, Jiashuo Zheng, Jiashuo Zheng
High Dietary Iron Has a Greater Impact on Brain Iron Homeostasis and Cognitive Function in Old Compared with Young C57BL/6J Male Mice. The Journal of nutrition 151 (9) (2022)
Jiashuo Zheng, Mami Sato, Eikan Mishima, Hideyo Sato, Bettina Proneth, Marcus Conrad
Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines. Cell death & disease 12 (7) (2021)